StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Aktis Oncology (AKTS)

Akoustis Technologies (AKTS) PT Raised to $35 at H.C. Wainwright June 3, 2026 6:49 AM - StreetInsider Aktis Oncology to Present at the Jefferies Global Healthcare Conference May 27, 2026 4:05 PM - StreetInsider Aktis reports imaging data for cancer drug targeting B7-H3 protein May 21, 2026 5:36 PM - StreetInsider Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors May 21, 2026 5:21 PM - Globe NewsWire Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026 May 11, 2026 4:01 PM - StreetInsider Aktis Oncology to Present at the BofA Securities Health Care Conference May 6, 2026 8:00 AM - Globe NewsWire Aktis Oncology starts Phase 1b trial for prostate cancer drug AKY-2519 May 4, 2026 4:05 PM - StreetInsider Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC) May 4, 2026 4:05 PM - Globe NewsWire Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB May 3, 2026 8:00 PM - BizWire William Blair Starts Akoustis Technologies (AKTS) at Outperform April 29, 2026 6:40 AM - StreetInsider Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting April 21, 2026 5:00 PM - StreetInsider Aktis Oncology adds Daiichi Sankyo veteran Glenn Gormley to board April 16, 2026 11:43 AM - StreetInsider Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors April 16, 2026 11:42 AM - Globe NewsWire Aktis Oncology adds Glenn Gormley to board of directors April 16, 2026 8:00 AM - StreetInsider Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors April 16, 2026 8:00 AM - StreetInsider Akoustis Technologies (AKTS) PT Raised to $33 at H.C. Wainwright March 31, 2026 6:38 AM - StreetInsider Aktis Oncology receives FDA clearance for AKY-2519 drug trials March 30, 2026 4:01 PM - StreetInsider Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results March 30, 2026 4:01 PM - StreetInsider Full Article List